US2976146A
(en)
|
1958-11-28 |
1961-03-21 |
Eastman Kodak Co |
Novel cyan-forming couplers
|
BE790440A
(es)
|
1971-10-23 |
1973-04-24 |
Bayer Ag |
|
JPS538707B2
(es)
|
1974-02-05 |
1978-03-31 |
|
|
JPS50106981U
(es)
|
1974-02-08 |
1975-09-02 |
|
|
US3906953A
(en)
|
1974-05-23 |
1975-09-23 |
American Optical Corp |
Endoscopic surgical laser system
|
SU509578A1
(ru)
|
1974-09-19 |
1976-04-05 |
Стерлитамакский Химический Завод |
Способ получени пропилендиаминов
|
IE43079B1
(en)
*
|
1975-03-20 |
1980-12-17 |
Ici Ltd |
Quinolone derivatives
|
GB1502312A
(en)
|
1975-03-20 |
1978-03-01 |
Ici Ltd |
Quinolone derivatives
|
FR2311776A1
(fr)
*
|
1975-05-23 |
1976-12-17 |
Sogeras |
Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
|
GB1570494A
(en)
*
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
JPS5382783U
(es)
|
1976-12-13 |
1978-07-08 |
|
|
JPS5382783A
(en)
|
1976-12-29 |
1978-07-21 |
Yamanouchi Pharmaceut Co Ltd |
Novel pyridone derivs and process for their preparation
|
JPS5752334Y2
(es)
|
1977-03-16 |
1982-11-13 |
|
|
US4196207A
(en)
*
|
1977-05-23 |
1980-04-01 |
Ici Australia Limited |
Process for controlling eradicating or preventing infestations of animals by Ixodid ticks
|
DE2750288A1
(de)
*
|
1977-11-10 |
1979-05-17 |
Thomae Gmbh Dr K |
Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
|
JPS6057300B2
(ja)
|
1980-09-11 |
1985-12-14 |
株式会社東芝 |
超電導コイル間のエネルギ転送装置
|
US4432979A
(en)
|
1981-10-26 |
1984-02-21 |
William H. Rorer, Inc. |
Pyridone compounds
|
EP0082023A3
(en)
|
1981-12-16 |
1983-07-20 |
Sankyo Company Limited |
Thienopyrimidine derivatives, their preparation and their medical use
|
US4358453A
(en)
*
|
1982-01-08 |
1982-11-09 |
Schering Corporation |
1,2,4-Triazolo[4,3-a]pyridines
|
US4520025A
(en)
|
1982-07-21 |
1985-05-28 |
William H. Rorer, Inc. |
Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
US4550166A
(en)
*
|
1984-05-21 |
1985-10-29 |
American Cyanamid Company |
(Pyridinyl)-1,2,4-triazolo[4,3-a]pyridines
|
US5175157A
(en)
*
|
1985-11-27 |
1992-12-29 |
Boehringer Ingelheim Gmbh |
Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
|
DE3717561A1
(de)
|
1987-05-25 |
1988-12-08 |
Thomae Gmbh Dr K |
Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US4866074A
(en)
*
|
1987-05-08 |
1989-09-12 |
Rorer Pharmaceutical Corporation |
Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their uses
|
EP0308020A3
(en)
|
1987-09-18 |
1990-12-05 |
Merck & Co. Inc. |
5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
|
US5260293A
(en)
*
|
1988-01-30 |
1993-11-09 |
Merck Sharp & Dohme Limited |
Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
|
GB8804448D0
(en)
|
1988-02-25 |
1988-03-23 |
Smithkline Beckman Intercredit |
Compounds
|
JP2614081B2
(ja)
*
|
1988-05-27 |
1997-05-28 |
大塚化学株式会社 |
光学活性β−ラクタム誘導体の製造法
|
JPH02124871A
(ja)
|
1988-07-27 |
1990-05-14 |
Dainippon Pharmaceut Co Ltd |
1位が置換された複素環式カルボン酸アミド誘導体
|
DE68923527D1
(de)
|
1988-10-20 |
1995-08-24 |
Sandoz Ag |
Faserreaktive Azofarbstoffe.
|
US5032602A
(en)
*
|
1988-12-14 |
1991-07-16 |
Bayer Aktiengesellschaft |
Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones
|
HU206337B
(en)
|
1988-12-29 |
1992-10-28 |
Mitsui Petrochemical Ind |
Process for producing pyrimidine derivatives and pharmaceutical compositions
|
JPH02277044A
(ja)
|
1989-04-19 |
1990-11-13 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
US5236917A
(en)
*
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
US5280026A
(en)
*
|
1989-05-30 |
1994-01-18 |
Smithkline Beecham Intercredit B.V. |
Thienopyrimidines
|
AU622330B2
(en)
*
|
1989-06-23 |
1992-04-02 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
|
US4978663A
(en)
*
|
1989-08-16 |
1990-12-18 |
Hoechst-Roussel Pharmaceuticals Inc. |
5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
|
GB8926560D0
(en)
|
1989-11-24 |
1990-01-17 |
Zambeletti Spa L |
Pharmaceuticals
|
IL96432A0
(en)
|
1989-11-30 |
1991-08-16 |
Schering Ag |
Pesticidal compositions containing pyridine derivatives and novel pyridine derivatives
|
DE3940480A1
(de)
*
|
1989-12-07 |
1991-06-13 |
Bayer Ag |
Chromogene enaminverbindungen, ihre herstellung und verwendung als farbbildner
|
AU6979091A
(en)
|
1989-12-22 |
1991-07-24 |
Upjohn Company, The |
Pyridinones useful as antiatherosclerotic agents
|
FR2657610A1
(fr)
|
1990-01-29 |
1991-08-02 |
Rhone Poulenc Agrochimie |
Triazolopyridines herbicides.
|
GB9104238D0
(en)
|
1990-03-16 |
1991-04-17 |
Ici Pharma |
3-tetrazolylthiomethyl cephalosporin antibiotics
|
DE4008726A1
(de)
|
1990-03-19 |
1991-09-26 |
Basf Ag |
Thieno(2,3-d)pyrimidinderivate
|
BR9101256A
(pt)
|
1990-03-30 |
1991-11-05 |
Dowelanco |
Composto,composicao fungicida,processo fungicida,composicao inseticida ou acaricida e processo inseticida ou acaricida
|
RU1796625C
(ru)
|
1990-06-27 |
1993-02-23 |
Киевский Государственный Университет Им.Т.Г.Шевченко |
3-Амино-7-нитро-4(2,3,4-триметоксифенил)-2-фенил-1(2Н)изохинолон, обладающий аналептическим действием
|
EP0478195B1
(en)
|
1990-09-21 |
1999-05-26 |
Rohm And Haas Company |
Dihydropyridazinones and pyridazinones as fungicides
|
KR920008026A
(ko)
|
1990-10-24 |
1992-05-27 |
오노 화아마슈티칼 캄파니 리미팃드 |
이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
|
WO1992018115A1
(en)
|
1991-04-18 |
1992-10-29 |
Dr Lo Zambeletti S.P.A. |
Use of heterocyclic compounds for the treatment of inflammatory pain
|
DE4122240A1
(de)
|
1991-07-05 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Dibenz(b,e)azepinderivate und diese enthaltende arzneimittel
|
US5332750A
(en)
*
|
1991-09-04 |
1994-07-26 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
1,2-dihydro-2-oxopyridines
|
DE4129340A1
(de)
|
1991-09-04 |
1993-03-11 |
Merck Patent Gmbh |
1,2-dihydro-2-oxopyridine
|
DE4131924A1
(de)
*
|
1991-09-25 |
1993-07-08 |
Hoechst Ag |
Substituierte 4-alkoxypyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
US5204198A
(en)
*
|
1991-10-28 |
1993-04-20 |
Eastman Kodak Company |
Photoelectrographic elements utilizing nonionic sulfonic acid photogenerators
|
US5416099A
(en)
|
1991-10-29 |
1995-05-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
DE4221583A1
(de)
*
|
1991-11-12 |
1993-05-13 |
Bayer Ag |
Substituierte biphenylpyridone
|
JP2878531B2
(ja)
*
|
1991-12-16 |
1999-04-05 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料
|
AU668694B2
(en)
|
1991-12-19 |
1996-05-16 |
Sanofi-Synthelabo |
Saccharin derivative proteolytic enzyme inhibitors
|
US5378720A
(en)
*
|
1991-12-19 |
1995-01-03 |
Sterling Winthrop Inc. |
Saccharin derivative proteolytic enzyme inhibitors
|
TW219935B
(es)
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
GB9200293D0
(en)
|
1992-01-08 |
1992-02-26 |
Wyeth John & Brother Ltd |
Piperazine derivatives
|
GB9201694D0
(en)
|
1992-01-27 |
1992-03-11 |
Smithkline Beecham Intercredit |
Compounds
|
JPH05204071A
(ja)
|
1992-01-29 |
1993-08-13 |
Konica Corp |
ハロゲン化銀写真感光材料
|
JP3042156B2
(ja)
|
1992-02-20 |
2000-05-15 |
田辺製薬株式会社 |
ナフタレン誘導体、その製法及びその合成中間体
|
DE4206045A1
(de)
*
|
1992-02-27 |
1993-09-02 |
Bayer Ag |
Sulfonylbenzyl substituierte pyridone
|
US5922773A
(en)
*
|
1992-12-04 |
1999-07-13 |
The Children's Medical Center Corp. |
Glaucoma treatment
|
AU660132B2
(en)
*
|
1992-12-21 |
1995-06-08 |
Bayer Aktiengesellschaft |
Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
|
JPH06211798A
(ja)
|
1993-01-19 |
1994-08-02 |
Tosoh Corp |
テトラヒドロイソキノリノン誘導体及びその製造方法
|
JPH06211797A
(ja)
|
1993-01-19 |
1994-08-02 |
Tosoh Corp |
テトラヒドロイソキノリン誘導体、その製法及び抗真菌剤
|
SE9300657D0
(sv)
|
1993-02-26 |
1993-02-26 |
Astra Ab |
New compounds
|
US5814645A
(en)
*
|
1993-03-24 |
1998-09-29 |
Bayer Aktiengesellschaft |
Arylor hetaryl substituted nitrogen heterocycles and their use as pesticides
|
DE4316077A1
(de)
*
|
1993-05-13 |
1994-11-17 |
Bayer Ag |
Substituierte Mono- und Bihydridylmethylpyridone
|
WO1994029273A1
(en)
|
1993-06-09 |
1994-12-22 |
Smithkline Beecham Corporation |
Bicyclic fibrinogen antagonists
|
DE4326758A1
(de)
|
1993-08-10 |
1995-02-16 |
Basf Ag |
[1,3,4]Triazolo[1,5-a]pyridine
|
JPH07101861A
(ja)
|
1993-08-10 |
1995-04-18 |
Tanabe Seiyaku Co Ltd |
抗喘息薬
|
DE69409652T2
(de)
|
1993-08-19 |
1998-10-15 |
Janssen Pharmaceutica Nv |
Gefässverengende substituierte aryloxyalkyldiamine
|
ATE256130T1
(de)
|
1993-08-19 |
2003-12-15 |
Janssen Pharmaceutica Nv |
Gefässverengende dihydrobenzopyranderivate
|
WO1995006032A1
(en)
|
1993-08-20 |
1995-03-02 |
Banyu Pharmaceutical Co., Ltd. |
Tyrosine kinase inhibitor
|
JP3701984B2
(ja)
|
1993-08-31 |
2005-10-05 |
サントリー株式会社 |
ラベル化シクロプロパン誘導体およびその製造方法
|
US5424435A
(en)
*
|
1993-10-18 |
1995-06-13 |
Olin Corporation |
1-hydroxy-6-substituted-2-pyridones
|
US5500420A
(en)
*
|
1993-12-20 |
1996-03-19 |
Cornell Research Foundation, Inc. |
Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
|
US5679683A
(en)
*
|
1994-01-25 |
1997-10-21 |
Warner-Lambert Company |
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
TW282456B
(es)
|
1994-03-10 |
1996-08-01 |
Fujisawa Yakusin Kogyo Kk |
|
ES2079323B1
(es)
|
1994-06-21 |
1996-10-16 |
Vita Invest Sa |
Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
|
GB9416554D0
(en)
|
1994-08-19 |
1994-10-12 |
Ciba Geigy Ag |
Glutamate receptor
|
WO1996005828A1
(en)
|
1994-08-24 |
1996-02-29 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
|
US6017697A
(en)
|
1994-11-14 |
2000-01-25 |
Eli Lilly And Company |
Excitatory amino acid receptor protein and related nucleic acid compounds
|
US5473077A
(en)
*
|
1994-11-14 |
1995-12-05 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
|
US5512576A
(en)
*
|
1994-12-02 |
1996-04-30 |
Sterling Winthrop Inc. |
2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
US5789426A
(en)
|
1995-01-20 |
1998-08-04 |
Cornell Research Foundation, Inc. |
Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
|
US5869486A
(en)
|
1995-02-24 |
1999-02-09 |
Ono Pharmaceutical Co., Ltd. |
Fused pyrimidines and pyriazines as pharmaceutical compounds
|
DE19507522C2
(de)
|
1995-03-03 |
2003-05-28 |
Basf Ag |
Verfahren zur Herstellung von 3,4-Dihydroisochinolinverbindungen und 3,4-Dihydroisochinolinium-Salzen
|
US5869428A
(en)
*
|
1995-03-13 |
1999-02-09 |
Ishihara Sangyo Kaisha Ltd. |
Pyridonesulfonylurea compounds, process for their production and herbicides containing them
|
DE19510965A1
(de)
*
|
1995-03-24 |
1996-09-26 |
Asta Medica Ag |
Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
|
CA2219364A1
(en)
|
1995-04-27 |
1996-10-31 |
Hideki Okunishi |
Heterocyclic amide compounds and pharmaceutical use thereof
|
JPH08325248A
(ja)
|
1995-05-26 |
1996-12-10 |
Chugoku Kayaku Kk |
テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
|
US5849587A
(en)
|
1995-06-09 |
1998-12-15 |
Cornell Research Foundation, Inc. |
Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
|
US5659033A
(en)
|
1995-09-13 |
1997-08-19 |
Neurogen Corporation |
N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
|
TR199800464T1
(xx)
|
1995-09-15 |
1998-05-21 |
Synthelabo |
Serotonin antagonistleri olarak kinolein-2(1H)-on t�revleri
|
JPH1045750A
(ja)
|
1995-09-20 |
1998-02-17 |
Takeda Chem Ind Ltd |
アゾール化合物、その製造方法及び用途
|
US6130217A
(en)
|
1995-09-20 |
2000-10-10 |
Pfizer Inc |
Compounds enhancing antitumor activity of other cytotoxic agents
|
AR004010A1
(es)
|
1995-10-11 |
1998-09-30 |
Glaxo Group Ltd |
Compuestos heterociclicos
|
IL123568A
(en)
|
1995-12-08 |
2001-08-08 |
Janssen Pharmaceutica Nv |
History (Imidazole - 5Il) Methyl-2-quinolinone inhibitors of Prenzyl transferase, their preparation, pharmaceutical preparations containing them and their preparation and drugs containing them
|
US6313127B1
(en)
|
1996-02-02 |
2001-11-06 |
Zeneca Limited |
Heterocyclic compounds useful as pharmaceutical agents
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
GB9602294D0
(en)
*
|
1996-02-05 |
1996-04-03 |
Zeneca Ltd |
Heterocyclic compounds
|
US6084084A
(en)
|
1996-02-21 |
2000-07-04 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
US5710274A
(en)
*
|
1996-02-28 |
1998-01-20 |
Neurogen Corporation |
N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
|
US5756518A
(en)
|
1996-04-02 |
1998-05-26 |
Kowa Co., Ltd. |
Phenylene derivatives
|
JPH1029979A
(ja)
|
1996-04-12 |
1998-02-03 |
Ajinomoto Co Inc |
新規ピリジン誘導体
|
US5741798A
(en)
*
|
1996-06-03 |
1998-04-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
2-benzyl-4-sulfonyl-4H-isoquinolin-1,3-diones and their use as antiinflammatory agents
|
US6391027B1
(en)
|
1996-07-04 |
2002-05-21 |
Erbe Elektromedizin Gmbh |
Gas-aided, axially displaceable surgical electrode
|
WO1998006724A1
(fr)
|
1996-08-09 |
1998-02-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Agonistes du recepteur du glutamate metabotropique
|
DE19632423A1
(de)
*
|
1996-08-12 |
1998-02-19 |
Merck Patent Gmbh |
Thienopyrimidine
|
KR20000029984A
(ko)
*
|
1996-08-14 |
2000-05-25 |
사라 엔 람베쓰 |
치환된피리미딘유도체및이의약학적용도
|
CA2265672C
(en)
|
1996-09-16 |
2008-12-02 |
Du Pont Pharmaceuticals Company |
Pyrazinones and triazinones and their derivatives thereof
|
DE19638484A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
DE19638486A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
DE19644228A1
(de)
|
1996-10-24 |
1998-04-30 |
Merck Patent Gmbh |
Thienopyrimidine
|
US6284794B1
(en)
|
1996-11-05 |
2001-09-04 |
Head Explorer Aps |
Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
|
NZ335992A
(en)
|
1996-12-05 |
2001-09-28 |
Amgen Inc |
Substituted pyrimidinone and pyridone compounds and methods of use
|
DE69812934T2
(de)
|
1997-01-24 |
2004-01-29 |
Conpharma As Oslo |
Gemcitabin-derivate
|
US5855654A
(en)
|
1997-01-30 |
1999-01-05 |
Rohm And Haas Company |
Pyridazinones as marine antifouling agents
|
FR2759366B1
(fr)
|
1997-02-11 |
1999-04-16 |
Centre Nat Rech Scient |
Composes constituant notamment des effecteurs de recepteurs du systeme nerveux central sensibles aux amino acides neuroexcitateurs, leur preparation et leurs applications biologiques
|
US6262068B1
(en)
|
1997-02-21 |
2001-07-17 |
Bristol-Myers Squibb Company |
Lactam derivatives as antiarrhythmic agents
|
AU6230098A
(en)
|
1997-02-27 |
1998-09-18 |
Tanabe Seiyaku Co., Ltd. |
Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
|
ES2131463B1
(es)
|
1997-04-08 |
2000-03-01 |
Lilly Sa |
Derivados de ciclopropilglicina con propiedades farmaceuticas.
|
GB9708945D0
(en)
|
1997-05-01 |
1997-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE19728996A1
(de)
|
1997-07-07 |
1999-01-14 |
Basf Ag |
Triazolverbindungen und deren Verwendung
|
JP2001515839A
(ja)
|
1997-07-18 |
2001-09-25 |
ジョージタウン・ユニバーシティ |
二環式向代謝性グルタミン酸受容体リガンド
|
DE69804273T2
(de)
*
|
1997-07-18 |
2002-10-31 |
Hoffmann La Roche |
5h-Thiazolo[3,2-a]pyrimidinderivate
|
ATE238052T1
(de)
|
1997-07-31 |
2003-05-15 |
Celgene Corp |
Susstituierte alkanhydroxamisaeure und verfahren zur verminderung des tnf-alphaspiegels
|
YU6100A
(sh)
*
|
1997-08-14 |
2002-10-18 |
F.Hoffmann-La Roche Ag. |
Heterociklični viniletri protiv neuroloških poremećaja
|
US6358975B1
(en)
|
1997-08-15 |
2002-03-19 |
Johns Hopkins University |
Method of using selective parp inhibitors to prevent or treat neurotoxicity
|
US6197785B1
(en)
|
1997-09-03 |
2001-03-06 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
|
AU9298098A
(en)
|
1997-09-03 |
1999-03-22 |
Guilford Pharmaceuticals Inc. |
Amino-substituted compounds, methods, and compositions for inhibiting parp activity
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US20020028813A1
(en)
|
1997-09-03 |
2002-03-07 |
Paul F. Jackson |
Thioalkyl compounds, methods, and compositions for inhibiting parp activity
|
US6121278A
(en)
|
1997-09-03 |
2000-09-19 |
Guilford Pharmaceuticals, Inc. |
Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
|
US20020022636A1
(en)
|
1997-09-03 |
2002-02-21 |
Jia-He Li |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
AU9740998A
(en)
|
1997-09-08 |
1999-03-29 |
F. Hoffmann-La Roche Ag |
Piperidine derivatives against malaria
|
EP0903343B1
(en)
|
1997-09-19 |
2003-05-28 |
SSP Co., Ltd. |
Alpha-Substituted phenylpropionic acid derivative and medicine containing the same
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
WO2000012089A1
(en)
|
1998-08-31 |
2000-03-09 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
WO1999016755A1
(en)
|
1997-09-26 |
1999-04-08 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
US6162804A
(en)
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO1999018096A1
(en)
|
1997-10-02 |
1999-04-15 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
BR9814820A
(pt)
|
1997-10-14 |
2000-10-03 |
Welfide Corp |
Compostos de piperazina e seu uso médico
|
WO1999021992A2
(en)
|
1997-10-23 |
1999-05-06 |
Ganimed Pharmaceuticals Gmbh |
Nucleic acid molecules encoding a glutamate receptor
|
WO1999031062A1
(fr)
|
1997-12-17 |
1999-06-24 |
Shionogi & Co., Ltd. |
Nouveaux composes de pyridine
|
US6054470A
(en)
|
1997-12-18 |
2000-04-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Src family SH2 domain inhibitors
|
US6013672A
(en)
*
|
1997-12-18 |
2000-01-11 |
Uab Research Foundation |
Agonists of metabotropic glutamate receptors and uses thereof
|
KR20010033241A
(ko)
|
1997-12-19 |
2001-04-25 |
스티븐 엠. 오드레 |
치환된 피리딘 및 피리다진 화합물과 그것의 제약학적 용도
|
FR2772763B1
(fr)
|
1997-12-24 |
2004-01-23 |
Sod Conseils Rech Applic |
Nouveaux analogues tetracycliques de camptothecines, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
IT1298155B1
(it)
|
1998-01-19 |
1999-12-20 |
Moreno Paolini |
Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della
|
US6664250B2
(en)
|
1998-01-20 |
2003-12-16 |
Bristol-Myers Squibb Co. |
Lactam derivatives as antiarrhythmic agents
|
KR100446892B1
(ko)
|
1998-01-28 |
2004-09-04 |
다이쇼 세이야꾸 가부시끼가이샤 |
함불소 아미노산 유도체
|
NZ506417A
(en)
|
1998-02-17 |
2003-05-30 |
Tularik Inc |
Anti-viral pyrimidine derivatives
|
SK13532000A3
(sk)
|
1998-03-17 |
2002-07-02 |
Pfizer Products Inc. |
Bicyklo [2.2.1] heptány a príbuzné zlúčeniny, farmaceutické kompozície a spôsoby liečenia na ich báze
|
CN1295570A
(zh)
|
1998-04-08 |
2001-05-16 |
诺瓦提斯公司 |
N-吡啶酮基除草剂
|
WO1999053956A1
(fr)
|
1998-04-16 |
1999-10-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Remedes contre l'obesite
|
EP0955301A3
(en)
|
1998-04-27 |
2001-04-18 |
Pfizer Products Inc. |
7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
|
DE19822198C2
(de)
|
1998-05-16 |
2003-02-13 |
Wella Ag |
Oxonolfarbstoffe enthaltende Mittel und Verfahren zur Erzeugung von semipermanenten Färbungen auf Haaren
|
WO1999062908A2
(en)
|
1998-06-04 |
1999-12-09 |
Abbott Laboratories |
Cell adhesion-inhibiting antinflammatory compounds
|
DE19826671A1
(de)
|
1998-06-16 |
1999-12-23 |
Hoechst Schering Agrevo Gmbh |
1,3-Oxazolin- und 1,3-Thiazolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
|
FR2781218B1
(fr)
|
1998-07-15 |
2001-09-07 |
Lafon Labor |
Compositions pharmaceutiques comprenant des 2-quinolones
|
JP2000072751A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
イソキノリノン誘導体
|
DE69918136T2
(de)
|
1998-08-31 |
2005-07-07 |
Taisho Pharmaceutical Co., Ltd. |
6-Fluorobicyclo[3.1.0]Hexan-Derivate
|
JP2000072731A
(ja)
|
1998-08-31 |
2000-03-07 |
Taisho Pharmaceut Co Ltd |
4−置換−2−アミノビシクロ[3.1.0]ヘキサン−2,6−ジカルボン酸誘導体及び製薬用組成物
|
CH694053A5
(de)
|
1998-09-03 |
2004-06-30 |
Hoffmann La Roche |
Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
|
US6284759B1
(en)
|
1998-09-30 |
2001-09-04 |
Neurogen Corporation |
2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
|
SE9803518D0
(sv)
|
1998-10-15 |
1998-10-15 |
Astra Pharma Prod |
Novel compounds
|
PE20001236A1
(es)
|
1998-11-13 |
2000-11-10 |
Lilly Co Eli |
Moduladores del receptor de aminoacidos excitadores
|
US6133271A
(en)
*
|
1998-11-19 |
2000-10-17 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
|
US5948911A
(en)
*
|
1998-11-20 |
1999-09-07 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
|
EP1006112A1
(en)
|
1998-12-01 |
2000-06-07 |
Cerebrus Pharmaceuticals Limited |
3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
|
US6184231B1
(en)
|
1998-12-04 |
2001-02-06 |
Bristol-Myers Squibb |
3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
|
US6575913B1
(en)
|
1999-02-01 |
2003-06-10 |
A.C. Cossor & Son (Surgical) Limited |
Relating to sphygmometers
|
LU90358B1
(fr)
|
1999-03-01 |
2000-09-05 |
Iee Sarl |
Dispositif pour arr-ter le d-loiement d'un airbag dans un v-hicule
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TW564247B
(en)
|
1999-04-08 |
2003-12-01 |
Akzo Nobel Nv |
Bicyclic heteraromatic compound
|
GB9908175D0
(en)
|
1999-04-09 |
1999-06-02 |
Lilly Co Eli |
Method of treating neurological disorders
|
US6972296B2
(en)
|
1999-05-07 |
2005-12-06 |
Encysive Pharmaceuticals Inc. |
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
US6723711B2
(en)
|
1999-05-07 |
2004-04-20 |
Texas Biotechnology Corporation |
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
WO2000069816A1
(en)
|
1999-05-17 |
2000-11-23 |
Eli Lilly And Company |
Metabotropic glutamate receptor antagonists
|
NO313534B1
(no)
|
1999-06-01 |
2002-10-21 |
Hanne Storm |
Apparat og fremgangsmåte for overvåkning og fremgangsmåte for styring av et varselsignal
|
NZ515894A
(en)
|
1999-06-02 |
2003-09-26 |
Nps Pharma Inc |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
WO2000075101A1
(en)
|
1999-06-03 |
2000-12-14 |
Lilly, S.A. |
Excitatory amino acid receptor modulators
|
CA2390948A1
(en)
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
JP4783967B2
(ja)
|
1999-07-21 |
2011-09-28 |
大正製薬株式会社 |
含フッ素アミノ酸誘導体を有効成分とする医薬
|
WO2001010846A2
(en)
|
1999-08-05 |
2001-02-15 |
Igt Pharma Inc. |
1,4-diazepine derivatives for the treatment of diseases related to the central nervous system
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
US7040838B2
(en)
|
1999-08-27 |
2006-05-09 |
Kristar Enterprises, Inc. |
High capacity catch basin filtration system with adjustable deflector ring
|
CN2390948Y
(zh)
|
1999-09-17 |
2000-08-09 |
徐平武 |
混凝土屋顶、楼面施工金属组合专用模具
|
BR0014859A
(pt)
|
1999-10-15 |
2002-07-16 |
Hoffmann La Roche |
Derivados de benzodiazepina
|
TR200201026T2
(tr)
|
1999-10-15 |
2002-08-21 |
F.Hoffmann-La Roche Ag |
Benzodiazepin türevleri
|
JP3822494B2
(ja)
|
1999-10-19 |
2006-09-20 |
メルク エンド カムパニー インコーポレーテッド |
チロシンキナーゼ阻害剤
|
EP1230225A2
(en)
|
1999-11-01 |
2002-08-14 |
Eli Lilly And Company |
Pharmaceutically active 4-substituted pyrimidine derivatives
|
GB2355982A
(en)
|
1999-11-03 |
2001-05-09 |
Lilly Co Eli |
Heterocyclic amino acids
|
AU2220801A
(en)
|
1999-12-22 |
2001-07-03 |
Kyorin Pharmaceutical Co. Ltd. |
Tricyclic compounds and addition salts thereof
|
CA2398388A1
(en)
|
2000-01-20 |
2001-07-26 |
Koji Kato |
Novel piperidine compound and pharmaceutical thereof
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
WO2001056990A2
(en)
*
|
2000-02-03 |
2001-08-09 |
Eli Lilly And Company |
Pyridine derivates as potentiators of glutamate receptors
|
ES2240449T3
(es)
|
2000-02-25 |
2005-10-16 |
F. Hoffmann-La Roche Ag |
Moduladores receptores de adenosina.
|
DE10012373A1
(de)
|
2000-03-14 |
2001-09-20 |
Dresden Arzneimittel |
Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
|
GB0007108D0
(en)
|
2000-03-23 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
EP1268432A1
(en)
|
2000-03-24 |
2003-01-02 |
Millenium Pharmaceuticals, Inc. |
ISOQUINOLONE INHIBITORS OF FACTOR Xa
|
GB0007193D0
(en)
|
2000-03-25 |
2000-05-17 |
Univ Manchester |
Treatment of movrmrnt disorders
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
DK1277754T3
(da)
|
2000-04-27 |
2005-11-14 |
Astellas Pharma Inc |
Imidazopyridinderivater
|
EP1288199A4
(en)
|
2000-04-28 |
2005-10-12 |
Shionogi & Co |
INHIBITORS OF MMP-12
|
CZ301809B6
(cs)
|
2000-04-28 |
2010-06-30 |
Nihon Nohyaku Co., Ltd. |
Zpusob prípravy 2-halogenbenzoových kyselin a jejich derivátu
|
JP2004507457A
(ja)
|
2000-05-11 |
2004-03-11 |
協和醗酵工業株式会社 |
2−ピペリドン化合物
|
US20020009713A1
(en)
|
2000-05-11 |
2002-01-24 |
Miller Freda D. |
Methods for identifying modulators of neuronal growth
|
MXPA02011053A
(es)
|
2000-05-11 |
2004-08-19 |
Kenneth Curry |
Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos.
|
US7081481B2
(en)
|
2000-05-31 |
2006-07-25 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
US6949571B2
(en)
|
2000-06-12 |
2005-09-27 |
Eisai Co., Ltd. |
1,2-dihydropyridine compounds, process for preparation of the same and use thereof
|
JP2002003401A
(ja)
|
2000-06-27 |
2002-01-09 |
Japan Science & Technology Corp |
脳由来神経栄養因子誘導剤
|
JP2002012533A
(ja)
*
|
2000-06-27 |
2002-01-15 |
Kao Corp |
染毛剤組成物
|
JP2004501627A
(ja)
|
2000-06-27 |
2004-01-22 |
センター ナショナル デ ラ レシェルルシェ サイエンティフィック−シーエヌアールエス |
哺乳動物2pドメインメカノ感受性k+チャネル、そのクローニングおよび利用
|
WO2002000605A1
(fr)
|
2000-06-28 |
2002-01-03 |
Taisho Pharmaceutical Co., Ltd. |
Nouveaux derives d'acide dicarboxylique
|
DE10031390A1
(de)
|
2000-07-03 |
2002-01-17 |
Knoll Ag |
Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
|
US20020041880A1
(en)
*
|
2000-07-05 |
2002-04-11 |
Defeo-Jones Deborah |
Method of treating cancer
|
JP2002069057A
(ja)
|
2000-07-07 |
2002-03-08 |
Kyowa Hakko Kogyo Co Ltd |
ピペリジン誘導体
|
JP2002040252A
(ja)
|
2000-07-27 |
2002-02-06 |
Shiseido Co Ltd |
コレステリック液晶層を含む光学シート、それを用いた情報記録体、情報記録方法並びに情報判別方法
|
DE10038019A1
(de)
|
2000-08-04 |
2002-02-14 |
Bayer Ag |
Substituierte Triazolopyrid(az)ine
|
IL153995A0
(en)
|
2000-08-11 |
2003-07-31 |
Eisai Co Ltd |
2-aminopyridine derivatives and pharmaceutical compositions containing the same
|
WO2002022598A1
(en)
|
2000-09-11 |
2002-03-21 |
Chiron Corporation |
Quinolinone derivatives as tyrosine kinase inhibitors
|
AU2002213422A1
(en)
|
2000-09-13 |
2002-03-26 |
Georgetown University |
Synthesis of 2-hydroxymethylglutamic acid and congeners thereof
|
JP2002105085A
(ja)
|
2000-09-28 |
2002-04-10 |
Yamanouchi Pharmaceut Co Ltd |
新規イミダゾチアゾール誘導体
|
KR100818965B1
(ko)
|
2000-10-02 |
2008-04-04 |
얀센 파마슈티카 엔.브이. |
대사자극성 글루타메이트 수용체 길항제
|
FI20002525A
(fi)
|
2000-11-17 |
2002-05-18 |
Orion Yhtymae Oyj |
Tulehduksenvastaisia aineita
|
DE10058663A1
(de)
|
2000-11-25 |
2002-05-29 |
Merck Patent Gmbh |
Verwendung von Thienopyrimidinen
|
JPWO2002051849A1
(ja)
|
2000-12-26 |
2004-04-22 |
第一製薬株式会社 |
Cdk4活性阻害剤
|
TWI287004B
(en)
|
2000-12-28 |
2007-09-21 |
Shionogi & Co |
A pyridone derivative having an affinity effect for cannabinoid 2 type receptor
|
JP2002308882A
(ja)
|
2001-02-08 |
2002-10-23 |
Yamanouchi Pharmaceut Co Ltd |
チエノピリミジン誘導体
|
US20030130264A1
(en)
|
2001-02-16 |
2003-07-10 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
EP1975620A3
(en)
|
2001-03-02 |
2008-12-24 |
GPC Biotech AG |
Three hybrid assay system
|
DE10291003D2
(de)
|
2001-03-08 |
2004-04-15 |
Ilfa Industrieelektronik Und L |
Mehrschichtige Leiterplatte
|
US6596731B2
(en)
|
2001-03-27 |
2003-07-22 |
Hoffmann-La Roche Inc. |
Substituted imidazo[1,2-A] pyridine derivatives
|
JP2004527244A
(ja)
|
2001-04-02 |
2004-09-09 |
メルク エンド カムパニー インコーポレーテッド |
受容体型キナーゼ阻害剤の活性のインビボ測定方法
|
CZ20033002A3
(cs)
|
2001-04-12 |
2004-03-17 |
F. Hoffmann-La Roche Ag |
Deriváty dihydrobenzo [b] [1,4]diazepin-2-onu jako antagonisty mGluR2
|
IL157873A0
(en)
|
2001-04-12 |
2004-03-28 |
Hoffmann La Roche |
DIHYDRO-BENZO [b] [1,4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
|
SE0101579D0
(sv)
|
2001-05-04 |
2001-05-04 |
Astrazeneca Ab |
New compounds
|
EP1392309B1
(en)
*
|
2001-05-14 |
2007-01-17 |
Bristol-Myers Squibb Company |
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
|
US7144903B2
(en)
|
2001-05-23 |
2006-12-05 |
Amgen Inc. |
CCR4 antagonists
|
CA2448317A1
(en)
|
2001-05-30 |
2002-12-05 |
Alteon Inc. |
Method for treating glaucoma v
|
EP1406611A2
(en)
|
2001-05-30 |
2004-04-14 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
WO2002098869A2
(en)
|
2001-06-05 |
2002-12-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzo-fused cycloalkyl urea compounds
|
CA2451057A1
(en)
|
2001-06-14 |
2002-12-27 |
Banyu Pharmaceutical Co., Ltd. |
Novel isoxazolopyridone derivatives and use thereof
|
HUP0402352A2
(hu)
|
2001-06-19 |
2005-02-28 |
Bristol-Myers Squibb Co. |
Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
|
JP2003012653A
(ja)
|
2001-06-28 |
2003-01-15 |
Yamanouchi Pharmaceut Co Ltd |
キナゾリン誘導体
|
EP1411941A2
(en)
|
2001-08-02 |
2004-04-28 |
Neurocrine Biosciences, Inc. |
Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
|
JP2005508904A
(ja)
|
2001-09-11 |
2005-04-07 |
スミスクライン ビーチャム コーポレーション |
血管新生阻害剤としてのフロ−及びチエノピリミジン誘導体
|
AU2002341920A1
(en)
|
2001-10-02 |
2003-04-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
TWI330183B
(es)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
TW200406466A
(en)
|
2001-11-13 |
2004-05-01 |
Ciba Sc Holding Ag |
Compositions comprising at least one oxonol dye and at least one metal complex
|
US6921762B2
(en)
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
GB0129260D0
(en)
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
KR20040068240A
(ko)
|
2001-12-14 |
2004-07-30 |
노보 노르디스크 에이/에스 |
호르몬 민감성 리파아제의 활성을 감소시키기 위한 화합물및 그들의 사용
|
AU2002351412B2
(en)
|
2001-12-21 |
2010-05-20 |
Exelixis Patent Company Llc |
Modulators of LXR
|
RU2315622C2
(ru)
|
2001-12-27 |
2008-01-27 |
Тайсо Фармасьютикал Ко.,Лтд. |
Производные 6-фторбицикло[3.1.0]гексана
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
JP2005170790A
(ja)
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
N−アルキルスルフォニル置換アミド誘導体
|
EP1465862A1
(en)
|
2002-01-17 |
2004-10-13 |
SmithKline Beecham Corporation |
Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
US20050113283A1
(en)
*
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
WO2003064428A1
(en)
|
2002-01-29 |
2003-08-07 |
H. Lundbeck A/S |
Furano- and thienopyrimidines as neurokinase inhibitors
|
US6949542B2
(en)
|
2002-02-06 |
2005-09-27 |
Hoffman-La Roche Inc. |
Dihydro-benzo[b][1,4]diazepin-2-one derivatives
|
JP2005516988A
(ja)
|
2002-02-07 |
2005-06-09 |
ユニバーシティー オブ マイアミ |
シュヴァン細胞およびホスホジエステラーゼインヒビターに基づく治療
|
US20040116489A1
(en)
|
2002-02-12 |
2004-06-17 |
Massey Steven Marc |
Synthetic excitatory amino acids
|
CA2476162A1
(en)
|
2002-02-13 |
2003-08-21 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
KR100705519B1
(ko)
|
2002-02-14 |
2007-04-10 |
파마시아 코포레이션 |
P38 map 키나제의 조절제로서의 치환된 피리디논
|
WO2003070712A1
(en)
|
2002-02-19 |
2003-08-28 |
H. Lundbeck A/S |
Thioibotenic acid and derivatives thereof
|
US6833380B2
(en)
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
WO2003076405A1
(en)
|
2002-03-14 |
2003-09-18 |
Bayer Healthcare Ag |
Monocyclic aroylpyridinones as antiinflammatory agents
|
AU2003225964B2
(en)
|
2002-03-28 |
2008-11-20 |
Merck Sharp & Dohme Corp. |
Substituted 2,3-diphenyl pyridines
|
JP4573533B2
(ja)
*
|
2002-03-29 |
2010-11-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
放射能標識付きキノリンおよびキノリノン誘導体および代謝向性グルタメート受容体リガンドとしてのそれらの使用
|
AU2003218063A1
(en)
|
2002-04-03 |
2003-10-20 |
Eli Lilly And Company |
Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
|
US6864261B2
(en)
|
2002-05-02 |
2005-03-08 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
JP2005530745A
(ja)
|
2002-05-02 |
2005-10-13 |
メルク エンド カムパニー インコーポレーテッド |
チロシンキナーゼ阻害剤
|
CA2485166A1
(en)
|
2002-05-21 |
2003-12-04 |
Amgen Inc. |
Substituted pyrimidinone and pyridinone compounds
|
CA2390348A1
(en)
|
2002-06-10 |
2003-12-10 |
Ibm Canada Limited-Ibm Canada Limitee |
Systems, methods and computer programs for implementing and accessing webservices
|
PT1517915E
(pt)
|
2002-06-11 |
2009-04-09 |
Lilly Co Eli |
Pró-drogas de amino ácidos de excitação
|
ES2277088T3
(es)
|
2002-06-13 |
2007-07-01 |
Vertex Pharmaceuticals Incorporated |
Derivados del acido 2-ureido-6-heteroaril-3h-benzoimidazol-4-carboxilico y compuestos relacionados como inhibidores de girasa y/o topoisomerasa iv para el tratamiento de infecciones bacterianas.
|
GB0214268D0
(en)
|
2002-06-20 |
2002-07-31 |
Celltech R&D Ltd |
Chemical compounds
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
AU2003246927A1
(en)
|
2002-07-03 |
2004-01-23 |
Astex Technology Limited |
3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
US7262194B2
(en)
|
2002-07-26 |
2007-08-28 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US20040138238A1
(en)
|
2002-08-08 |
2004-07-15 |
Dhanoa Dale S. |
Substituted aminopyrimidine compounds as neurokinin antagonists
|
GB0218630D0
(en)
|
2002-08-10 |
2002-09-18 |
Tanabe Seiyaku Co |
Novel compounds
|
GB0218800D0
(en)
|
2002-08-13 |
2002-09-18 |
Celltech R&D Ltd |
Chemical compounds
|
AU2003255845A1
(en)
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
AU2003262805A1
(en)
|
2002-08-26 |
2004-03-11 |
Merck & Co., Inc. |
Acetophenone potentiators of metabotropic glutamate receptors
|
WO2004019863A2
(en)
|
2002-08-28 |
2004-03-11 |
Intermune, Inc. |
Combination therapy for treatment of fibrotic disorders
|
MY139563A
(en)
|
2002-09-04 |
2009-10-30 |
Bristol Myers Squibb Co |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
CN1694701A
(zh)
|
2002-09-10 |
2005-11-09 |
诺瓦提斯公司 |
治疗包括成瘾与抑郁症在内的与mGLU受体相关疾病的mGLU受体拮抗剂
|
WO2004024936A2
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Mutant forms of glutamate receptors mglur2 and mglur3
|
AU2003269628A1
(en)
|
2002-09-19 |
2004-04-08 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
JP4391426B2
(ja)
|
2002-09-19 |
2009-12-24 |
ベーリンガー インゲルハイム (カナダ) リミテッド |
非ヌクレオシド逆転写酵素インヒビター
|
AR044743A1
(es)
|
2002-09-26 |
2005-10-05 |
Nihon Nohyaku Co Ltd |
Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
US7998163B2
(en)
|
2002-10-03 |
2011-08-16 |
Boston Scientific Scimed, Inc. |
Expandable retrieval device
|
WO2004038034A1
(ja)
|
2002-10-23 |
2004-05-06 |
Daiichi Pure Chemicals Co., Ltd. |
新規なフルクトシルペプチドオキシダーゼとその利用
|
US20040138204A1
(en)
|
2002-10-30 |
2004-07-15 |
Harrington James Frederick |
Compositions and methods for pain reduction
|
EP1560827B1
(en)
|
2002-11-01 |
2010-12-29 |
Abbott Laboratories |
Anti-infective agents
|
US7902203B2
(en)
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
US6930117B2
(en)
|
2002-11-09 |
2005-08-16 |
The Procter & Gamble Company |
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
|
KR101052482B1
(ko)
|
2002-11-21 |
2011-07-28 |
노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 |
포스포티딜이노시톨(pi) 3-키나제 억제제인 2,4,6-삼치환피리미딘 및 암의 치료에서 이들의 사용
|
WO2004054979A1
(ja)
|
2002-12-18 |
2004-07-01 |
Takeda Pharmaceutical Company Limited |
Jnk阻害剤
|
US7173058B2
(en)
|
2002-12-30 |
2007-02-06 |
Celgene Corporation |
Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
|
ES2295816T3
(es)
|
2003-01-14 |
2008-04-16 |
Arena Pharmaceuticals, Inc. |
Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
|
ITMI20030151A1
(it)
|
2003-01-30 |
2004-07-31 |
Recordati Ind Chimica E Farma Ceutica S P A |
Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore.
|
CA2514267C
(en)
|
2003-02-04 |
2011-05-17 |
F. Hoffmann-La Roche Ag |
Malonamide derivatives as gamma-secretase inhibitors
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
SI1606282T1
(sl)
|
2003-02-24 |
2009-04-30 |
Arena Pharm Inc |
Fenilni in piridilpiperidinski derivati kot modulatorji glukoznega metabolizma
|
DE602004010791T2
(de)
|
2003-03-03 |
2008-12-04 |
F. Hoffmann-La Roche Ag |
2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
|
ITFI20030058A1
(it)
|
2003-03-06 |
2004-09-07 |
Univ Firenze |
Formulazioni farmaceutiche contenenti tiazolidinedioni
|
KR101022189B1
(ko)
|
2003-03-13 |
2011-03-17 |
가부시키가이샤 티라도 |
수증기 개질기
|
DE10311065A1
(de)
|
2003-03-13 |
2004-09-23 |
Abbott Gmbh & Co. Kg |
Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
CA2527170A1
(en)
|
2003-04-15 |
2004-10-28 |
Astrazeneca Ab |
Therapeutic compounds
|
JP2004339080A
(ja)
|
2003-05-13 |
2004-12-02 |
Tokyo Institute Of Technology |
ピラゾ−ル誘導体を含有する高血圧治療剤
|
JP4847868B2
(ja)
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
JP2007504283A
(ja)
|
2003-05-20 |
2007-03-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
β−アミロイド斑に作用物質を結合させる方法
|
GB0315950D0
(en)
|
2003-06-11 |
2003-08-13 |
Xention Discovery Ltd |
Compounds
|
WO2005002585A1
(en)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
WO2005007144A2
(en)
|
2003-07-14 |
2005-01-27 |
Decode Genetics Ehf |
Method of diagnosis and treatment for asthma based on haplotype association
|
GB0320300D0
(en)
|
2003-08-29 |
2003-10-01 |
Cancer Rec Tech Ltd |
Pyrimidothiophene compounds
|
NZ546044A
(en)
|
2003-08-29 |
2009-09-25 |
Vernalis Cambridge Ltd |
Pyrimidothiophene compounds
|
GB0322016D0
(en)
|
2003-09-19 |
2003-10-22 |
Merck Sharp & Dohme |
New compounds
|
EP1716125B1
(en)
|
2004-02-18 |
2013-06-19 |
AstraZeneca AB |
Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
US20070219234A1
(en)
|
2004-04-12 |
2007-09-20 |
Kiyoshi Oizumi |
Thienopyridine Derivatives
|
US7459562B2
(en)
*
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US8063004B2
(en)
|
2004-07-22 |
2011-11-22 |
Malcera, L.L.C. |
Chemical composition of matter for the liquefaction and dissolution of asphaltene and paraffin sludges into petroleum crude oils and refined products at ambient temperatures and method of use
|
WO2006014918A2
(en)
|
2004-07-30 |
2006-02-09 |
Merck & Co., Inc. |
Heterocyclic acetophenone potentiators of metabotropic glutamate receptors
|
JP2008508306A
(ja)
|
2004-07-30 |
2008-03-21 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体のインダノン増強剤
|
WO2006015737A1
(de)
|
2004-08-02 |
2006-02-16 |
Schwarz Pharma Ag |
Carboxamide des indolizins und seiner aza- und diazaderivate
|
EP1778093B1
(en)
|
2004-08-11 |
2013-04-03 |
Koninklijke Philips Electronics N.V. |
Ultrasonic diagnosis of ischemic cardiodisease
|
TW200613272A
(en)
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
JP2008509985A
(ja)
|
2004-08-18 |
2008-04-03 |
ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー |
炎症治療用の新規トリアゾロピリジン化合物
|
DE102004044884A1
(de)
|
2004-09-14 |
2006-05-24 |
Grünenthal GmbH |
Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
|
GB0420722D0
(en)
*
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
GB0420719D0
(en)
*
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
CA2584598A1
(en)
|
2004-10-25 |
2006-05-04 |
Merck & Co., Inc. |
Heterocyclic indanone potentiators of metabotropic glutamate receptors
|
CN101061105B
(zh)
|
2004-11-22 |
2012-05-30 |
伊莱利利公司 |
谷氨酸受体增效剂
|
US7434262B2
(en)
*
|
2004-12-08 |
2008-10-07 |
At&T Intellectual Property I, L.P. |
Methods and systems that selectively resurrect blocked communications between devices
|
DE102004061288A1
(de)
|
2004-12-14 |
2006-06-29 |
Schering Ag |
3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
|
JP2008525478A
(ja)
|
2004-12-27 |
2008-07-17 |
アストラゼネカ アクチボラグ |
神経系及び精神医学系障害の治療のための代謝共役型グルタミン酸受容体アゴニストとしてのピラゾロン化合物
|
US7456289B2
(en)
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
JP2008536802A
(ja)
|
2005-02-24 |
2008-09-11 |
メルク エンド カムパニー インコーポレーテッド |
代謝調節型グルタミン酸受容体のベンズアゾール増強剤
|
RU2412943C2
(ru)
|
2005-03-23 |
2011-02-27 |
Ф. Хоффманн-Ля Рош Аг |
ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2
|
JPWO2006109876A1
(ja)
|
2005-04-08 |
2008-11-20 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
不随意運動治療剤
|
US7579360B2
(en)
*
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US7572807B2
(en)
*
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
WO2006137350A1
(ja)
|
2005-06-22 |
2006-12-28 |
Kissei Pharmaceutical Co., Ltd. |
新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
|
RU2008101923A
(ru)
*
|
2005-08-05 |
2009-09-10 |
Астразенека Аб (Se) |
Трициклические бензимидазолы и их применение в качестве модуляторов метаботропного глутаматного рецептора
|
CN101277934A
(zh)
|
2005-08-12 |
2008-10-01 |
阿斯利康(瑞典)有限公司 |
使代谢型谷氨酸-受体-增效的异吲哚酮
|
WO2007027669A1
(en)
|
2005-08-29 |
2007-03-08 |
Cps Biofuels, Inc. |
Improved biodiesel fuel, additives, and lubbricants
|
EP1764099A3
(en)
*
|
2005-09-17 |
2007-05-09 |
Speedel Experimenta AG |
Diaminoalcohol derivatives for the treatment of Alzheimer, malaria, HIV
|
PT1948654E
(pt)
|
2005-09-17 |
2009-09-28 |
Novartis Ag |
Derivados da 5-amino-4-hidroxi-7-(imidazo[1,2-a] piridin-6-ilmetil)-8-metil-nonamida e compostos relacionados como inibidores da renina para o tratamento da hipertensão
|
WO2008051197A2
(en)
|
2005-09-20 |
2008-05-02 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
JP5048675B2
(ja)
|
2005-09-27 |
2012-10-17 |
エフ.ホフマン−ラ ロシュ アーゲー |
mGluR2アンタゴニストとしてのオキサジアゾリルピラゾロ−ピリミジン類
|
PT2090575E
(pt)
|
2005-11-15 |
2011-06-06 |
Array Biopharma Inc |
Inibidores de erbb
|
TW200732313A
(en)
|
2005-12-15 |
2007-09-01 |
Astrazeneca Ab |
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
|
TW200804281A
(en)
|
2006-02-16 |
2008-01-16 |
Astrazeneca Ab |
New metabotropic glutamate receptor-potentiating isoindolones
|
JP2009528388A
(ja)
|
2006-03-02 |
2009-08-06 |
スミスクライン・ビーチャム・コーポレイション |
Pi3キナーゼ阻害物質として用いられるチアゾロン
|
TWI417095B
(zh)
*
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
|
GB0606774D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
GB0608263D0
(en)
|
2006-04-26 |
2006-06-07 |
Glaxo Group Ltd |
Compounds
|
WO2007135529A2
(en)
|
2006-05-23 |
2007-11-29 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as mglur2 potentiators
|
WO2007135527A2
(en)
|
2006-05-23 |
2007-11-29 |
Pfizer Products Inc. |
Benzimidazolyl compounds
|
EP2039687B1
(en)
|
2006-06-19 |
2012-05-02 |
Toray Industries, Inc. |
Therapeutic or prophylactic agent for multiple sclerosis
|
CA2656855A1
(en)
|
2006-07-12 |
2008-01-17 |
Christoph Luthy |
Triazolopyridine derivatives as herbicides
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US8198448B2
(en)
*
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
WO2008012622A2
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
WO2008032191A2
(en)
|
2006-09-13 |
2008-03-20 |
Astrazeneca Ab |
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
|
CA2665195C
(en)
*
|
2006-10-11 |
2011-08-09 |
Amgen Inc. |
Imidazo- and triazolo-pyridine compounds and methods of use thereof
|
US7994190B2
(en)
|
2006-11-01 |
2011-08-09 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
AU2007337895C1
(en)
|
2006-12-22 |
2014-07-31 |
Astex Therapeutics Limited |
Tricyclic amine derivatives as protein tyrosine kinase inhibitors
|
CA2672172C
(en)
|
2006-12-22 |
2016-05-03 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
US20110053953A1
(en)
|
2007-02-09 |
2011-03-03 |
Abdelmalik Slassi |
AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
EP1968272A1
(en)
|
2007-03-05 |
2008-09-10 |
Matsushita Electric Industrial Co., Ltd. |
Loop detection for mobile IP home agents
|
CA2679965A1
(en)
|
2007-03-07 |
2008-09-12 |
Janssen Pharmaceutica N.V. |
Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
|
WO2008109737A1
(en)
|
2007-03-07 |
2008-09-12 |
Janssen Pharmaceutica N.V. |
Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
*
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
AR065622A1
(es)
|
2007-03-07 |
2009-06-17 |
Ortho Mcneil Janssen Pharm |
Derivados de 3-ciano -4- (4-fenil- piperidin -1- il) piridin -2- ona
|
AU2008222745A1
(en)
|
2007-03-07 |
2008-09-12 |
Janssen Pharmaceutica N.V. |
Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
|
GB0704407D0
(en)
|
2007-03-07 |
2007-04-18 |
Glaxo Group Ltd |
Compounds
|
CA2680262C
(en)
|
2007-03-09 |
2012-11-13 |
Sanofi-Aventis |
Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
|
WO2008124085A2
(en)
|
2007-04-03 |
2008-10-16 |
Exelixis, Inc. |
Methods of using combinations of mek and jak-2 inhibitors
|
WO2008130853A1
(en)
|
2007-04-17 |
2008-10-30 |
Astrazeneca Ab |
Hydrazides and their use as metabotropic glutamate receptor potentiators - 681
|
NZ581127A
(en)
|
2007-05-25 |
2012-06-29 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
|
TWI417100B
(zh)
*
|
2007-06-07 |
2013-12-01 |
Astrazeneca Ab |
二唑衍生物及其作為代謝型麩胺酸受體增效劑-842之用途
|
TW200911255A
(en)
|
2007-06-07 |
2009-03-16 |
Astrazeneca Ab |
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
|
WO2009004430A1
(en)
|
2007-06-29 |
2009-01-08 |
Pfizer Inc. |
N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
|
UA100126C2
(en)
*
|
2007-09-14 |
2012-11-26 |
Аддекс Фарма С.А. |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
|
JP5433579B2
(ja)
*
|
2007-09-14 |
2014-03-05 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
1,3−二置換−4−フェニル−1h−ピリジン−2−オン
|
PT2200985E
(pt)
*
|
2007-09-14 |
2011-07-21 |
Ortho Mcneil Janssen Pharm |
4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
|
WO2009041567A1
(ja)
|
2007-09-27 |
2009-04-02 |
Banyu Pharmaceutical Co., Ltd. |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールケチミン誘導体
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US8425426B2
(en)
*
|
2007-11-09 |
2013-04-23 |
Western Clinical Engineering, Ltd |
Tourniquet apparatus for measuring limb occlusion pressure
|
CN101861316B
(zh)
*
|
2007-11-14 |
2013-08-21 |
奥梅-杨森制药有限公司 |
咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
JP2011510083A
(ja)
|
2008-01-24 |
2011-03-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
3,5−二置換−1,3−オキサゾリジン−2−オン誘導体
|
EP2268645B1
(en)
|
2008-03-06 |
2014-11-12 |
Sanofi |
Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof as allosteric modulators of mglur
|
US10919672B2
(en)
|
2008-03-31 |
2021-02-16 |
Angelcare Feeding Usa, Llc |
Seal indication mechanism for containers
|
DE102008001056A1
(de)
|
2008-04-08 |
2009-10-15 |
Robert Bosch Gmbh |
Umlenkeinrichtung für einen Strahl einer elektromagnetischen Welle
|
EP2291078A4
(en)
|
2008-05-15 |
2011-08-24 |
Merck Sharp & Dohme |
OXAZOLBENZIMIDAZOLDERIVATE
|
CA2723729A1
(en)
|
2008-05-15 |
2009-11-19 |
Merck Sharp & Dohme Corp. |
Oxazolobenzimidazole derivatives
|
US7790760B2
(en)
|
2008-06-06 |
2010-09-07 |
Astrazeneca Ab |
Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
US20100037487A1
(en)
*
|
2008-08-14 |
2010-02-18 |
Susan Connett |
Method and apparatus for sandal with hidden strap adjustment
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
AU2009289784B2
(en)
|
2008-09-02 |
2012-03-22 |
Addex Pharma S.A. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
RU2517181C2
(ru)
|
2008-10-16 |
2014-05-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
|
BRPI0921333A2
(pt)
|
2008-11-28 |
2015-12-29 |
Addex Pharmaceuticals Sa |
derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
|
AT507619B1
(de)
|
2008-12-05 |
2011-11-15 |
Oesterreichisches Forschungs Und Pruefzentrum Arsenal Ges M B H |
Verfahren zur approximation des zeitlichen verlaufs von verkehrsdaten
|
JP5344222B2
(ja)
*
|
2008-12-26 |
2013-11-20 |
日本ガスケット株式会社 |
シリンダヘッドガスケットにおけるオイル落し穴のシール構造
|
EP2393807B1
(en)
|
2009-02-04 |
2013-08-14 |
Boehringer Ingelheim International GmbH |
Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
|
WO2010114726A1
(en)
|
2009-03-31 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Aminobenzotriazole derivatives
|
EP2417135A1
(en)
|
2009-04-07 |
2012-02-15 |
Schering Corporation |
Substituted triazolopyridines and analogs thereof
|
US8720829B2
(en)
|
2009-04-23 |
2014-05-13 |
Saab Ab |
Closable counter-measure compartments for a dispenser unit
|
BRPI1010831A2
(pt)
*
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
KR101753826B1
(ko)
*
|
2009-05-12 |
2017-07-04 |
얀센 파마슈티칼즈, 인코포레이티드 |
1,2,4―트리아졸로[4,3―a]피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도
|
WO2010141360A1
(en)
|
2009-06-05 |
2010-12-09 |
Merck Sharp & Dohme Corp. |
Biaryl benzotriazole derivatives
|
EP2470527A4
(en)
|
2009-08-20 |
2013-02-27 |
Merck Sharp & Dohme |
BENZOTRIAZOLE D ETHER DERIVATIVES
|
CN102002040A
(zh)
|
2009-09-01 |
2011-04-06 |
上海药明康德新药开发有限公司 |
一种三唑并吡啶环化合物的合成方法
|
AR078171A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
|
WO2011034741A1
(en)
|
2009-09-15 |
2011-03-24 |
Merck Sharp & Dohme Corp. |
Imidazopyridin-2-one derivatives
|
AR078173A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Bifeniloximetil dihidro oxazolopirimidinonas sustituidas, su preparacion y su uso
|
AR078172A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Fenoximetil dihidro oxazolopirimidinonas sustituidas y uso de las mismas como moduladores de receptores metabotropicos de mglur
|
JP5204071B2
(ja)
|
2009-09-25 |
2013-06-05 |
パナソニック株式会社 |
電気かみそり
|
US8507521B2
(en)
|
2009-11-02 |
2013-08-13 |
Merck Sharp + Dohme B.V. |
Heterocyclic derivatives
|
EP2542083B1
(en)
|
2010-03-04 |
2015-05-06 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
WO2011116356A2
(en)
|
2010-03-19 |
2011-09-22 |
Sanford-Burnham Medical Research Institute |
Positive allosteric modulators of group ii mglurs
|
US8314120B2
(en)
*
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
US8664214B2
(en)
|
2010-03-30 |
2014-03-04 |
AbbVie Deutschland GmbH & Co. KG |
Small molecule potentiators of metabotropic glutamate receptors I
|
US20130035332A1
(en)
|
2010-04-29 |
2013-02-07 |
Layton Mark E |
Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2
|
US8784289B2
(en)
|
2010-04-29 |
2014-07-22 |
Illinois Tool Works Inc. |
Process of forming a wide mouth gusseted bag with edge seals
|
BR112012027628A2
(pt)
|
2010-04-30 |
2016-08-09 |
Astrazeneca Ab |
polimorfos de um modulador alostérico positivo de receptor de glutamato metabotrópico
|
WO2011156245A2
(en)
|
2010-06-09 |
2011-12-15 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
CN101893589B
(zh)
*
|
2010-06-29 |
2012-10-17 |
中国人民解放军第三0二医院 |
一种无菌检查方法及其使用的全封闭集菌安瓿培养器
|
US8993779B2
(en)
|
2010-08-12 |
2015-03-31 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of MGLUR2
|
US8785481B2
(en)
*
|
2010-09-29 |
2014-07-22 |
Merck Sharp & Dohme Corp. |
Ether benzotriazole derivatives
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
US20130230459A1
(en)
|
2010-11-08 |
2013-09-05 |
Janssen Pharmaceuticals, Inc. |
RADIOLABELLED mGluR2 PET LIGANDS
|
EP2649069B1
(en)
|
2010-11-08 |
2015-08-26 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
US9139576B2
(en)
|
2011-05-03 |
2015-09-22 |
Merck Sharp & Dohme Corp. |
Aminomethyl biaryl benzotriazole derivatives
|
US20140088151A1
(en)
|
2011-05-03 |
2014-03-27 |
Douglas C. Beshore |
Alhydroxymethyl biaryl benzotriazole derivatives
|
US8772276B2
(en)
|
2011-05-03 |
2014-07-08 |
Merck Sharp & Dohme Corp. |
Alkyne benzotriazole derivatives
|